Wall Street analysts forecast that Permian Resources (PR) will report quarterly earnings of $0.44 per share in its upcoming release, pointing to a year-over-year increase of 4.8%. It is anticipated that revenues will amount to $1.39 billion, exhibiting an increase of 12.1% compared to the year-ago quarter.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 18.6% to its current level. This demonstrates the covering analysts' collective reassessment of their initial ...

Core Viewpoint - Cheniere Energy is expected to report quarterly earnings of $2.81 per share, reflecting a 31.9% increase year-over-year, with revenues projected at $4.47 billion, a 5.2% increase from the previous year [1]. Earnings Estimates - There has been a downward revision of 9.7% in the consensus EPS estimate over the last 30 days, indicating analysts' reassessment of their initial forecasts [2]. - Changes in earnings estimates are crucial for predicting investor reactions to the stock, as empirical research shows a strong correlation between earnings estimate revisions and short-term stock price performance [3]. Revenue Projections - Analysts estimate 'Revenues- LNG' to reach $4.29 billion, representing a 6.3% increase from the prior-year quarter [4]. - The 'Revenues- Other' is projected to be $148.90 million, indicating an 18.2% decrease from the previous year [5]. - The consensus estimate for 'Revenues- Regasification' is $33.37 million, reflecting a 1.9% decline from the year-ago quarter [5]. Stock Performance - Over the past month, Cheniere Energy shares have returned 16.5%, outperforming the Zacks S&P 500 composite's 11.5% change [6]. - Currently, Cheniere Energy holds a Zacks Rank 3 (Hold), suggesting its performance may align with the overall market in the near future [6].

Core Insights - Wall Street analysts forecast Blue Owl Capital Corporation (OBDC) will report quarterly earnings of $0.43 per share, reflecting a year-over-year decline of 8.5%, while revenues are expected to reach $452.85 million, indicating a 13.3% increase compared to the previous year [1] Earnings Estimates - The consensus EPS estimate has been revised downward by 0.4% in the past 30 days, indicating a reassessment by covering analysts [2] - Changes in earnings estimates are crucial for predicting investor reactions, with empirical studies showing a strong relationship between earnings estimate revisions and short-term stock price performance [3] Key Metrics Projections - Analysts project 'Investment income from non-controlled, non-affiliated investments - Interest income' to be $303.80 million, reflecting a year-over-year increase of 3.2% [5] - The estimated 'Investment income from non-controlled, non-affiliated investments - Other income' is $6.06 million, indicating a year-over-year change of 14.1% [5] - The average prediction for 'Investment income from controlled, affiliated investments - Dividend income' is $29.21 million, showing a change of 1.5% from the prior year [6] - Analysts expect 'Investment income from non-controlled, non-affiliated investments - Dividend income' to reach $22.44 million, reflecting a 5.2% increase from the previous year [6] - 'Investment income from controlled, affiliated investments - Interest income' is expected to be $7.82 million, indicating a year-over-year decline of 2.2% [7] - The consensus for 'Investment income from non-controlled, non-affiliated investments - Payment-in-kind interest income' is $47.70 million, reflecting a year-over-year increase of 15.7% [7] Stock Performance - Shares of Blue Owl Capital Corporation have increased by 7.9% in the past month, compared to a 11.5% increase in the Zacks S&P 500 composite [7] - With a Zacks Rank 4 (Sell), OBDC is expected to underperform the overall market in the near future [7]

Core Viewpoint - Wall Street analysts predict that Qiagen (QGEN) will report quarterly earnings of $0.50 per share, reflecting a year-over-year increase of 6.4%, with revenues expected to reach $464.04 million, a 1.1% increase compared to the previous year [1]. Earnings Estimates - The consensus EPS estimate for the quarter has remained unchanged over the past 30 days, indicating that analysts have not revised their initial projections [2]. - Revisions to earnings estimates are crucial as they serve as indicators for predicting investor actions regarding the stock, with empirical research showing a strong correlation between earnings estimate trends and short-term stock price performance [3]. Revenue and Sales Forecasts - Analysts forecast 'Sales by Product Groups- Diagnostic solutions- QIAstat-Dx' to reach $30.15 million, indicating a year-over-year change of +20.6% [5]. - 'Sales by Product Groups- Diagnostic solutions- QuantiFERON' is expected to reach $111.16 million, reflecting a year-over-year increase of +10.1% [5]. - The average prediction for 'Sales by Product Groups- Sample technologies' is $150.54 million, suggesting a year-over-year decrease of -2.9% [6]. - 'Sales by Product Groups- Diagnostic solutions' is projected to be $180.35 million, indicating a year-over-year increase of +6.1% [6]. - 'Sales by Product Groups- Diagnostic solutions- NeuMoDx' is expected to reach $4.60 million, reflecting a significant year-over-year decrease of -48.9% [7]. - 'Sales by Product Groups- Genomics / NGS' is projected at $54.60 million, indicating a slight decrease of -0.7% from the prior year [7]. - 'Sales by Product Groups- PCR / Nucleic acid amplification' is expected to reach $67.64 million, reflecting a year-over-year decrease of -0.5% [8]. - 'Revenue- Molecular Diagnostics' is anticipated to be $252.58 million, indicating a year-over-year increase of +3.5% [8]. - The consensus estimate for 'Revenue- Life Sciences' stands at $211.17 million, reflecting a year-over-year decrease of -1.8% [9]. - 'Sales by Product Groups- Diagnostic solutions- Other' is expected to be $34.45 million, indicating a year-over-year decrease of -1.6% [9]. Stock Performance - Qiagen shares have shown a return of +6.2% over the past month, compared to the Zacks S&P 500 composite's +11.5% change, with a Zacks Rank 2 (Buy), suggesting that QGEN is expected to outperform the overall market in the near future [9].

Group 1 - Analysts forecast that Dayforce (DAY) will report quarterly earnings of $0.56 per share, reflecting a year-over-year increase of 30.2% [1] - Expected revenues for Dayforce are projected to be $477.63 million, indicating a 10.7% increase compared to the same quarter last year [1] - The consensus EPS estimate has remained unchanged over the past 30 days, indicating that analysts have not revised their initial projections [2] Group 2 - Revisions to earnings estimates are crucial for predicting investor actions regarding the stock, as there is a strong correlation between earnings estimate trends and short-term price performance [3] - Analysts expect 'Revenue- Recurring' to be $421.40 million, showing a year-over-year change of +10.1% [5] - 'Revenue- Professional services and other' is anticipated to reach $55.49 million, reflecting a year-over-year increase of +13.7% [5] - 'Other recurring' revenue is forecasted to be $15.12 million, indicating a year-over-year decline of -22.5% [5] Group 3 - The total cloud recurring revenue is expected to reach $410.24 million, suggesting a year-over-year increase of +13% [6] - Dayforce shares have returned +14% over the past month, outperforming the Zacks S&P 500 composite's +11.5% change [6] - With a Zacks Rank 2 (Buy), Dayforce is anticipated to outperform the overall market in the near future [6]

The upcoming report from Edgewell Personal Care (EPC) is expected to reveal quarterly earnings of $0.90 per share, indicating an increase of 2.3% compared to the year-ago period. Analysts forecast revenues of $590.67 million, representing a decrease of 1.5% year over year.The consensus EPS estimate for the quarter has undergone a downward revision of 0.5% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates duri ...

Core Viewpoint - PENN Entertainment is expected to report a quarterly loss of $0.29 per share, a 63.3% increase in losses compared to the same period last year, with revenues projected at $1.7 billion, reflecting a year-over-year increase of 5.9% [1] Earnings Estimates - The consensus EPS estimate has been revised down by 48.6% over the last 30 days, indicating a significant reevaluation by analysts [2] - Revisions to earnings estimates are crucial indicators for predicting investor actions regarding the stock, with empirical research showing a strong correlation between earnings estimate trends and short-term stock price performance [3] Revenue Projections - Analysts estimate 'Revenues- West segment' to be $127.21 million, a decrease of 1.2% year over year [5] - The 'Revenues- Interactive segment' is projected at $312.88 million, indicating a substantial increase of 50.6% from the prior-year quarter [5] - 'Revenues- Midwest segment' is expected to reach $286.12 million, reflecting a year-over-year decline of 1.8% [5] - 'Revenues- Northeast segment' is projected at $683.75 million, showing a slight decrease of 0.1% from the year-ago quarter [6] - 'Revenues- South segment' is anticipated to be $287.13 million, indicating a year-over-year decline of 3.8% [6] - 'Revenues- Other segment' is expected to reach $6.15 million, reflecting a year-over-year increase of 2.5% [6] Adjusted EBITDAR Estimates - 'Adjusted EBITDAR- Midwest segment' is estimated at $111.47 million, down from $117 million in the previous year [7] - 'Adjusted EBITDAR- West segment' is projected at $45.25 million, slightly lower than the $45.90 million reported in the same quarter last year [7] - 'Adjusted EBITDAR- South segment' is expected to be $104.05 million, down from $113.50 million in the prior year [8] - 'Adjusted EBITDAR- Northeast segment' is projected at $200.12 million, compared to $202.60 million reported in the same quarter last year [8] Stock Performance - Over the past month, shares of PENN Entertainment have returned +12.6%, outperforming the Zacks S&P 500 composite's +11.5% change [8] - Currently, PENN carries a Zacks Rank 3 (Hold), suggesting its performance may align with the overall market in the near future [8]

Group 1 - Analysts project Wolverine World Wide (WWW) will announce quarterly earnings of $0.11 per share, a 120% increase year over year [1] - Revenues are expected to reach $395.35 million, reflecting a 0.1% increase from the same quarter last year [1] - The consensus EPS estimate has been revised downward by 9.4% in the past 30 days, indicating a reassessment by covering analysts [2] Group 2 - The average prediction for 'Revenue- Active Group' is $298.16 million, showing a year-over-year change of +2.9% [5] - 'Revenue- Other' is estimated to reach $13.10 million, indicating a decline of -12.7% from the prior-year quarter [5] - 'Revenue- Work Group' is expected to be $84.09 million, reflecting a year-over-year change of -6.7% [5] Group 3 - Wolverine shares have increased by +27.8% in the past month, outperforming the Zacks S&P 500 composite's +11.5% [6] - Wolverine holds a Zacks Rank 4 (Sell), suggesting it is expected to underperform the overall market in the near term [6]

Group 1 - The core viewpoint is that Triple Flag Precious Metals (TFPM) has significant upside potential, with a mean price target of $27.81 indicating a 32.8% increase from its current price of $20.94 [1] - Analysts have set 11 short-term price targets for TFPM, ranging from a low of $19 to a high of $36.50, with a standard deviation of $6.24, suggesting variability in estimates [2] - The consensus among analysts indicates that TFPM is expected to report better earnings than previously estimated, which historically correlates with stock price increases [4][11] Group 2 - The Zacks Consensus Estimate for TFPM's current year earnings has increased by 12.3% over the past month, with five estimates revised upward and no negative revisions [12] - TFPM holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13] - While price targets are often viewed skeptically, the direction implied by these targets can serve as a useful guide for potential stock movements [10][11]

Core Viewpoint - Wall Street analysts expect Insulet (PODD) to report quarterly earnings of $0.81 per share, reflecting an 11% year-over-year increase, with revenues projected at $541.33 million, a 22.6% increase compared to the same quarter last year [1]. Earnings Estimates - The consensus EPS estimate has been revised down by 1.1% in the past 30 days, indicating a reassessment by covering analysts [2]. - Revisions to earnings projections are crucial for predicting investor behavior and are linked to short-term stock price performance [3]. Revenue Projections - Analysts estimate 'Revenue- Total Omnipod' at $534.28 million, representing a 23.4% increase year-over-year [5]. - 'Revenue- Drug Delivery' is expected to reach $7.37 million, indicating a decline of 15.3% year-over-year [5]. - 'Revenue- International Omnipod' is projected at $144.78 million, reflecting a 25.6% increase year-over-year [5]. - 'Revenue- U.S. Omnipod' is estimated at $389.50 million, showing a 22.6% increase from the prior-year quarter [6]. Stock Performance - Over the past month, Insulet shares have returned +4.8%, outperforming the Zacks S&P 500 composite's +0.4% change [6]. - Currently, Insulet carries a Zacks Rank 4 (Sell), suggesting potential underperformance in the near future [6].